Biological constraints and operability in patents for bovine semen sexing technologies

Abstract

Bovine semen sexing technologies (BSST) have attracted sustained scientific and patenting activity due to their potential to improve reproductive efficiency and herd management in livestock systems. Numerous approaches have been proposed, including methods based on DNA content, sperm surface antigens, motility, size, density, and a range of physicochemical interactions. Despite this extensive activity, only DNA content-based flow cytometric sorting has demonstrated reproducible performance and practical adoption. This review evaluates BSST through the framework of reproductive biology, spermatogenesis, and evolutionary theory, with particular emphasis on the operability of patented methods rather than on reported enrichment outcomes alone. Published research and corresponding patent disclosures are classified into DNA content-based, immunological, motility/size/density-based, and miscellaneous categories. Evidence from proteomics, cytogenetics, sperm morphometry, and evolutionary constraints is examined to assess whether proposed mechanisms can plausibly generate stable, exploitable differences between X- and Y-chromosome-bearing sperm. The analysis shows that, apart from DNA content-based sorting, most BSST approaches rely on assumptions that conflict with established features of spermatogenesis, including chromatin condensation, cytoplasmic sharing among spermatids, and the evolutionary stability of sex ratios. By linking these biological constraints to persistent non-reproducibility, patent attrition, and lack of commercial translation, this review explains why entire classes of BSST methods continue to underperform despite decades of investigation. The findings provide a biologically grounded basis for evaluating innovation claims in reproductive technologies and for guiding future research and patent assessment in this field.